Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Gynecologic and Obstetric Investigation
|
January 1, 1987
Human follicular fluid levels of calcium, copper and zinc
S C Ng, R Karunanithy, W R Edirisinghe, et al.
Clinical Endocrinology
|
September 1, 1999
Association of molecular variants of luteinizing hormone with menstrual disorders
L N Ramanujam, W X Liao, A C Roy, et al.
Gynecologic and Obstetric Investigation
|
January 1, 1994
Interrelationships of serum paraoxonase, serum lipids and apolipoproteins in normal pregnancy. A longitudinal study
A C Roy, D F Loke, N Saha, et al.
Pediatrics
|
December 1, 1984
Cord plasma alpha-fetoprotein values and neonatal jaundice
K L Tan, A Loganath, A C Roy, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|
April 9, 2001
Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
S C Koh, K F Tham, K Razvi, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
November 1, 1995
A randomized controlled study of prostaglandin 15-methyl F2 alpha compared with syntometrine for prophylactic use in the third stage of labour
S Chua, S L Chew, C L Yeoh, et al.
Gynecologic and Obstetric Investigation
|
September 16, 1998
Correlation of change in uterine activity to blood loss in the third stage of labour
W L Choo, S Chua, Y S Chong, et al.
Human Biology
|
April 1, 1992
Genetic study of five populations of Bihar, India
N Saha, J S Tay, A C Roy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2013
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
A C Roy, S R Park, D Cunningham, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Gynecologic and Obstetric Investigation
|
January 1, 1987
Human follicular fluid levels of calcium, copper and zinc
S C Ng, R Karunanithy, W R Edirisinghe, et al.
Clinical Endocrinology
|
September 1, 1999
Association of molecular variants of luteinizing hormone with menstrual disorders
L N Ramanujam, W X Liao, A C Roy, et al.
Gynecologic and Obstetric Investigation
|
January 1, 1994
Interrelationships of serum paraoxonase, serum lipids and apolipoproteins in normal pregnancy. A longitudinal study
A C Roy, D F Loke, N Saha, et al.
Pediatrics
|
December 1, 1984
Cord plasma alpha-fetoprotein values and neonatal jaundice
K L Tan, A Loganath, A C Roy, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|
April 9, 2001
Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
S C Koh, K F Tham, K Razvi, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
November 1, 1995
A randomized controlled study of prostaglandin 15-methyl F2 alpha compared with syntometrine for prophylactic use in the third stage of labour
S Chua, S L Chew, C L Yeoh, et al.
Gynecologic and Obstetric Investigation
|
September 16, 1998
Correlation of change in uterine activity to blood loss in the third stage of labour
W L Choo, S Chua, Y S Chong, et al.
Human Biology
|
April 1, 1992
Genetic study of five populations of Bihar, India
N Saha, J S Tay, A C Roy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2013
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
A C Roy, S R Park, D Cunningham, et al.
Page
of 10